Evaluation of Prognostic Potentials of Gingival Crevicular Fluid E-cadherin and Total Antioxidant Capacity
Prognostic Potentials of E-cadherin and Total Antioxidant Capacity in Gingival Crevicular Fluid of Moderately Deep Periodontal Pockets Treated With Nonsurgical Periodontal Therapy
1 other identifier
interventional
20
1 country
1
Brief Summary
Ability to anticipate the outcomes of periodontal therapy at baseline visit is crucial to outline and customize a treatment plan with predictable outcomes and cost-effectiveness. Presence of diverse range of health/disease-associated molecules in oral environment that reflect health and disease, together with clinical parameters, is an appealing approach to use them as biomarkers to diagnose, predict, and monitor periodontal disease. Among these proteins are E-cad and TAC which available evidence indicate that their concentrations in oral biofluids increase remarkably during periodontitis as compared to healthy periodontium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2023
CompletedFirst Submitted
Initial submission to the registry
August 9, 2023
CompletedFirst Posted
Study publicly available on registry
August 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2023
CompletedAugust 16, 2023
August 1, 2023
10 months
August 9, 2023
August 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Probing pocket depth
Linear distance, in mm, measured from the gingival margin to the base of periodontal pocket or sulcus.
Baseline, 1 week, then 1 month and 3 months after treatment
Secondary Outcomes (4)
Clinical attachment loss
Baseline, 1 week, then 1 month and 3 months after treatment
Bleeding on probing
Baseline, 1 week, then 1 month and 3 months after treatment
Gingival crevicular fluid E-cadherin
Baseline, 1 month and 3 months after treatment
Total antioxidant capacity
Baseline, 1 month and 3 months after treatment
Study Arms (1)
Root surface debridement
OTHERPeriodontal pockets with PPD of 4 to 6mm are treated with root surface debridement only and assessed after 3 months for success/failure of treatment.
Interventions
the included patients will undergo full-mouth supra- and subgingival debridement by using ultrasonic device and manual instrumentation at baseline. This is followed, after 1 week, by performing root surface debridement for all pockets with PPD = 4-6 mm for each patient. All patients will be instructed to brush their teeth twice daily and will be supplied with the same type of tooth paste and toothbrush, with suitable interdental aids.
Eligibility Criteria
You may qualify if:
- Systemically healthy adult patients (\> 18 years).
- Periodontitis (interdental clinical attachment loss (CAL) detectable at ≥2 non-adjacent teeth, or buccal/oral CAL of ≥3mm with pocketing of \>3mm is detectable at ≥2 teeth). All patients should exhibit generalized periodontitis with pockets of PPD = 4 to 6 mm of any stage, unstable, and grade A to C. Only maxillary teeth with single root will be included.
You may not qualify if:
- Consumption of antibiotics or periodontal treatment 3-months prior to the study.
- Pregnancy and lactation.
- Smoker.
- History of systemic disease e.g., diabetes mellitus.
- Patients currently recruited in other trials.
- Patients not willing to consent.
- Periodontal pockets ≥ 7mm, active caries, endodontic problem.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Dentistry/ University of Baghdad
Baghdad, Iraq
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- The care provider is not aware about clinical parameters and biochemical analysis of GCF (E-cadherin and total antioxidant capacity).
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 9, 2023
First Posted
August 16, 2023
Study Start
February 15, 2023
Primary Completion
December 15, 2023
Study Completion
December 25, 2023
Last Updated
August 16, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share